Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Alliance Growers Corp ALGWF

Alliance Growers Corp is a Canada based diversified cannabis company. It principally operates through the four key divisions namely, Cannabis Botany Centre, Strategic Access to Cannabis for Medical Purposes Regulations Investments, Cannabidiol Oil Supply and Distribution, and Research and Development. The company is primarily focused on the development of Cannabis Botany Centres in Canada.


GREY:ALGWF - Post by User

Bullboard Posts
Comment by stoktikon Dec 29, 2016 8:42pm
97 Views
Post# 25652088

RE:Jason Schull given 3,352,050 ACG shares for manipulation

RE:Jason Schull given 3,352,050 ACG shares for manipulation
PRESS RELEASE
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES
FOR IMMEDIATE RELEASE
Early Warning Report Filed Pursuant
to National Instrument 62-103
Vancouver, British Columbia, June 22, 2015 – Jason Shull (the “
Offeror
”) announces that after
giving effect to Alliance
Growers Corp.’s (the “
Company
”) amalgamation (the “
RTO
”) under the
provisions of the
Business Corporations Act
(British Columbia), the Offeror indirectly acquired
2,750,000 common shares of the Company (the “
Acquired Securities
”) or 10.98% of the issued
and outstanding shares af
ter the RTO. Prior to the RTO, the Offeror held 602,050 common shares
of the Company both directly and indirectly. As
such, after the RTO, the Offeror owns 3,352,050
common shares of the Company or 13.3% of the i
ssued and outstanding shares after the RTO.
The Acquired Securities were acquired for invest
ment purposes. The Offeror may from time to
time acquire additional securities of the Company, di
spose of some or all of the securities of the
Company or maintain its current se
curities position in the Company.
The Acquired Securities were issued to the Of
feror on the basis of one common share for each
issued and outstanding common shar
e of Alliance Biotech Corp. he
ld by the Offeror pursuant to
the terms of the Amalgamation Agreement betw
een the Company, Alliance Biotech Corp., and
Sheslay Acquisition Corp. The Acquired Securi
ties were acquired pursuant to applicable
prospectus exemptions set out in
National Instrument
45-106 – Prospectus Exemptions
.
This press release is being issued pursuant to National Instrument 62-103 –
The Early
Warning System and Related Take-Over
Bid and Insider Re
porting Issuers.
A copy of the early
warning report filed under appli
cable securities laws is availa
ble under the Company’s profile on
SEDAR (www.sedar.com).
A copy of which shall be sent pr
omptly to anyone who requests it
from the representative of the Offeror noted below.
The name and address of the “Offeror” filing the report is:
Jason Shull
3601 Mathers Avenue
West Vancouver, BC V7V 2K8

Bullboard Posts